急性低氧时Wistar大鼠与高原鼠兔肺组织内皮型一氧化氮合酶基因表达的变化

目的探讨内皮型一氧化氮合酶(endothelial nitric oxide synthase, eNOS)在高原动物适应高原低氧环境中的作用.方法通过模拟4000m、6000m高原低氧,运用免疫组织化学技术,分别检测Wistar大鼠和高原鼠兔肺血管内皮和肺内气道上皮内皮型一氧化氮合酶蛋白表达水平的变化.结果无论是在肺血管内皮,还是肺内气道上皮,Wistar 大鼠eNOS蛋白表达在模拟4000m与6000m高原低氧处理2h后,均显著升高,而高原鼠兔基本保持不变,但高原鼠兔气道上皮eNOS的基础表达水平显著高于Wistar大鼠.结论相比Wistar大鼠,高原鼠兔eNOS基因表达在模拟高原低氧时增加较少甚或无明显增加,eNOS是急性高原低氧耐受过程中的一个重要机制.     

慢性高原低氧对高原鼠兔和大鼠肝脏的作用

我们曾经发现,移入高原的实验大鼠子一代和高原鼠兔(Ochotona curzoniae)对高原低气压低氧有完全不同的适应能力和适应机理(杜继曾等,1982)。我们还观察到,在24小时急性高原低氧时,由低地移入2300米高原的大鼠后裔在5000米和8000米的高度上,出现了以转氨酶、肝溶酶体酸性磷酸酶活力升高、肝糖原和蛋白质含量下降的肝脏代谢异常和肝脏病理变化,而高原鼠兔只是在8000米高度时,才始出现部分指标的轻度变异(杜继曾等,1982),从而揭示了高原鼠兔的肝细胞代谢在细胞水平上对低氧的适应机制优越于移入高原的实验大鼠后代。慢性低氧又如何作用于大鼠和高原鼠兔的肝脏代谢?迄今尚无人研究。因此对这一作用规律的认识和阐明,在环境适应生理学领域、人类高原活动和畜牧业生产上都是十分重要的。     

急性及慢性低氧对大白鼠和高原鼠兔肝线粒体呼吸功能的影响

本实验用氧电极法测定在急性及慢性低氧条件下,S.D大白鼠及高原鼠兔(Ochotona curzoniae)肝线粒体的氧化磷酸化效率及呼吸控制率之变化。结果表明:大白鼠和高原鼠兔经24小时急性低氧暴露后,其氧化磷酸化效率无明显变化;呼吸控制率在高原鼠兔中无明显变化,而在大白鼠中却有明显增加,这种增加是由于呼吸状态Ⅳ呼吸速度降低而引起的。经25天的慢性低氧暴露后,大白鼠和高原鼠兔的氧化磷酸化效率仍无明显变化,但大白鼠在海拔7000米时的呼吸控制率则有明显下降,而高原鼠兔却明显增加。实验结果提示:在细胞呼吸水平方面,高原鼠兔对低氧的耐受力明显高于大鼠。     

高原鼢鼠和高原鼠兔心脏对低氧环境的适应

为了探讨高原鼢鼠和高原鼠兔心脏对低氧环境的适应机制,以Sprague-Dawley (SD)大鼠为对照,测量三者的心脏/体重比(HW/BW)、右心室/(左心室 室间隔)重量比[RV/(LV S)];应用免疫组织化学方法测定心肌微血管密度(microvessel density, MVD);通过显微体视学技术比较线粒体的面数密度(NA,单位面积中线粒体数目)、体密度(Vv,单位体积心肌纤维中线粒体的体积密度)、面密度(Sv,单位体积心肌纤维中线粒体外膜的面积密度)、比表面(δ,线粒体外膜面积与其自身体积的比);用分光光度法测定心肌中的肌红蛋白(myoglobin, Mb)含量、乳酸(lactic acid, LD)含量和乳酸脱氢酶(lactate dehydrogenase, LDH)活力;聚丙烯酰胺凝胶电泳观察LDH同工酶谱.结果显示:高原鼢鼠和高原鼠兔HB/WB显著大于SD大鼠(P<0.05), RV/(LV S)显著小于SD大鼠(P<0.05).高原鼢鼠、高原鼠兔和SD大鼠心肌MVD和线粒体NA依次递减(P<0.05);高原鼢鼠线粒体Vv显著低于高原鼠兔和SD大鼠(P<0.05),高原鼠兔与SD大鼠之间没有明显差异;高原鼢鼠线粒体Sv显著高于SD大鼠(P<0.05),与高原鼠兔相比无明显差异;高原鼠兔和SD大鼠的线粒体δ无显著差异,但均明显低于高原鼢鼠(P<0.05).高原鼢鼠和高原鼠兔心肌Mb含量显著高于SD大鼠(P<0.05);高原鼢鼠心肌LD含量显著高于高原鼠兔和SD大鼠(P<0.05);两种高原动物心肌LDH活力显著低于SD大鼠(P<0.05).同工酶谱显示,高原鼢鼠、高原鼠兔和SD大鼠的LDH中H亚基所占比例依次递减.以上结果提示,高原鼢鼠和高原鼠兔通过增加心肌线粒体Sv、MVD以及Mb含量提高其在低氧环境获取氧的能力;同时,由于生境和习性上的不同,两者线粒体指标又表现出差异性.     

高原鼠兔低氧诱导因子- 1α的初步研究

Hypoxia-induced factor-1 plays a key role during the cell hypoxia trausduction. Hypoxia induced factor-1α (HIF-1α) is a functional subunit of hypoxia-indueed factor-1. Plateau pika ( Ochotona curron/ae), which is a Qinghai-Tibet plateau native animal lived above 3 000 m, has high ratio of oxygen utilization to adapt to plateau hypoxia environments. One fragment of the coding re-gion of eDNA sequence of plateau pika HIF-1α was obtained by RT-PCR technique using a degeneracy PCR primer based on previ-ously reported eDNA sequence in human, cattle, house mouse and Norway rat HIF-1α gene. It was directly inserted into the vector pMD18-T. DNA sequencing proved that it was highly homology with human (91%), cattle (91%), house mouse (89%) and Nor-way rat 89%) HIF-1α gene. The study provides basic important information for the HIF-1α cDNA whole sequence cloning of pla-teau pika and its functional study.     

低氧对雄性高原鼠兔性腺的影响

在人工模拟低氧环境下（低压舱模拟５０００ｍ和７０００ｍ海拔高度）,低氧暴露２４ｈ和７ｄ,观察低氧对受试动物性腺的影响。结果表明,急性低氧２４ｈ,高原鼠兔血浆雌二醇（Ｅ２）明显升高;低氧暴露７ｄ,高原鼠兔血浆Ｅ２仍维持一较高水平;５０００ｍ低氧暴露７ｄ,其睾丸指数无明显变化,７０００ｍ时却有所降低。同等条件下,大鼠睾丸指数明显增高;５０００ｍ和７０００ｍ低氧暴露７ｄ对高原鼠兔睾丸组织形态无明显影响,然而,大鼠曲细精管间隙增大,且曲细精管内各级细胞排列紊乱。低氧环境下,高原鼠兔雄体血浆Ｅ２增高,可能是其低氧适应的特征之一     

高原鼢鼠和高原鼠兔红细胞低氧适应特征

为探讨高原鼢鼠对低氧高二氧化碳洞道生境及高原鼠兔对高海拔低氧生境的适应机制,用Sysmex SF-3000血细胞分析仪及聚丙烯酰胺凝胶电泳对两种高原动物的血常规及血红蛋白类型进行分析,后者采用聚丙烯酰胺凝胶电泳法。结果表明,高原鼢鼠和高原鼠兔的红细胞数(RBC)、红细胞压积(HCT)及平均红细胞容积(MCV)组间无显著差异(P>0.05),但高原鼢鼠和高原鼠兔的红细胞数显著高于SD大鼠,红细胞压积及平均红细胞容积均显著低于SD大鼠(P<0.05);高原鼢鼠的血红蛋白浓度(HBC)与SD大鼠无显著差异(P>0.05),但显著高于高原鼠兔的HBC(P<0.05)。高原鼢鼠血红蛋白主要有2种类型,高原鼠兔血红蛋白主要有3种类型,而SD大鼠血红蛋白主要有5种类型。从血红蛋白电泳迁移来看,2种高原动物血红蛋白类型有明显的趋同特征并与SD大鼠具有明显的差异。上述结果提示,长期适应高海拔低氧环境的高原动物的红细胞和血红蛋白表现出趋同进化,同时因生境和习性的差异又表现出各自的特异性。     

低氧对高原鼠兔和大白鼠肝脏重要金属元素的影响

低氧对高原鼠兔和大白鼠肝脏重要金属元素的影响ＴＨＥＥＦＦＥＣＴＳＯＦＨＹＰＯＸＩＡＯＮＩＭＰＯＲＴＡＮＴＭＥＴＡＬＥＬＥＭＥＮＴＳＩＮＴＨＥＬＩＶＥＲＯＦＰＬＡＴＥＡＵＰＩＫＡＡＮＤＲＡＴ微量元素在动物生长、发育、繁衍等生命过程中具有重要的生理生化...     

高原鼠兔低氧适应分子机制的研究进展

高原鼠兔（Ochotona curzoniae）是生活在青藏高原海拔3000-5000m地区的特有物种,具有极强的低温、低氧耐受能力。近十几年来,许多国内外学者从整体水平及分子水平对高原鼠兔的低氧适应机制进行了大量研究,认为该动物是研究低氧适应的理想动物模型。本文对高原鼠兔的低氧适应机制从血液学特征、肺血管的结构和功能及分子生物学研究等方面作一系统阐述,旨在阐明高原土生动物在高寒缺氧环境中生存的适应机制,这对人类适应高原及高原疾病的防治有着重要的指导意义。     

Multimodality imaging of nitric oxide and nitric oxide synthases

Nitric oxide (NO) and NO synthases (NOSs) are crucial factors in many pathophysiological processes such as inflammation, vascular/neurological function, and many types of cancer. Noninvasive imaging of NO or NOS can provide new insights in understanding these diseases and facilitate the development of novel therapeutic strategies. In this review, we will summarize the current state-of-the-art multimodality imaging in detecting NO and NOSs, including optical (fluorescence, chemiluminescence, and bioluminescence), electron paramagnetic resonance (EPR), magnetic resonance (MR), and positron emission tomography (PET). With continued effort over the last several years, these noninvasive imaging techniques can now reveal the biodistribution of NO or NOS in living subjects with high fidelity which will greatly facilitate scientists/clinicians in the development of new drugs and/or patient management. Lastly, we will also discuss future directions/applications of NO/NOS imaging. Successful development of novel NO/NOS imaging agents with optimal in vivo stability and desirable pharmacokinetics for clinical translation will enable the maximum benefit in patient management.     

Mitochondrial nitric oxide synthase is constitutively active and is functionally upregulated in hypoxia

Nitric oxide is a potent modulator of mitochondrial respiration, ATP synthesis, and K_ATP channel activity. Recent studies show the presence of a potentionally new isoform of the nitric oxide synthase (NOS) enzyme in mitochondria, although doubts have emerged regarding the physiological relevance of mitochondrial NOS (mtNOS). The aim of the present study were to: (i) examine the existence and distribution of mtNOS in mouse tissues using three independent methods, (ii) characterize the cross-reaction of mtNOS with antibodies against the known isoforms of NOS, and (iii) investigate the effect of hypoxia on mtNOS activity. Nitric oxide synthase activity was measured in isolated brain and liver mitochondria using the arginine to citrulline conversion assay. Mitochondrial NOS activity in the brain was significantly higher than in the liver. The calmodulin inhibitor calmidazolium completely inhibited mtNOS activity. In animals previously subjected to hypoxia, mtNOS activity was significantly higher than in the normoxic controls. Antibodies against the endothelial (eNOS), but not the neuronal or inducible isoform of NOS, showed positive immunoblotting. Immunogold labeling of eNOS located the enzyme in the matrix and the inner membrane using electron microscopy. We conclude that mtNOS is a constitutively active eNOS-like isoform and is involved in altered mitochondrial regulation during hypoxia.     

Exogenous nitric oxide inhibits IRS-1 expression in rat hepatocytes and skeletal myocytes

Summary Accumulative evidence has supported the role of nitric oxide (NO) in a variety of normal physiological functions as well as many pathological conditions. In this study, we examined the possible diabetogenicity of NO by measuring the expression of the insulin receptor substrate (IRS)-1 in rat hepatocytes and skeletal myocytes. IRS-1 is important in the insulin-mediated signal transduction pathway in both liver and skeletal muscle. Exogenous NO donated by S-nitroso-N-acetylpenicillamine (SNAP) and S-nitrosoglutathione (GSNO) resulted in significant reduction in levels of IRS-1 in both cells, when compared to the insulin-stimulated control (p<0.001). Reversal to near normal levels was achieved using the NO scavenger 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide (carboxy-PTIO). SNAP was the more potent drug, and the skeletal myocytes were the more sensitive cells to the inhibitory effects of NO released from the drugs. These results provide further evidence that exogenous NO is a potent modulator of insulin-mediated signal transduction and may play a significant role in the pathogenesis of type 2 diabetes mellitus.     

Role of endogenous nitric oxide (NO) and NO synthases in healing of indomethacin-induced intestinal ulcers in rats

We examined the roles of nitric oxide (NO) and NO synthase (NOS) isozymes in the healing of indomethacin-induced small intestinal ulcers in rats. Animals were given indomethacin (10 mg/kg, s.c.) and killed 1, 4 and 7 days after the administration. Indomethacin (2 mg/kg), N(G)-nitro-L-arginine methyl ester (L-NAME: a nonselective NOS inhibitor: 10 mg/kg) and aminoguanine (a relatively selective iNOS inhibitor: 20 mg/kg) were given s.c. once daily for 6 days, the first 3 days or the last 3 days during a 7-day experimental period. Both indomethacin and L-NAME significantly impaired healing of these lesions, irrespective of whether they were given for 6 days, first 3 days or last 3 days. The healing was also impaired by aminoguanine given for the first 3 days but not for the last 3 days. Expression of iNOS mRNA in the intestine was up-regulated after ulceration, persisting for 2 days thereafter, and the Ca(2+)-independent iNOS activity also markedly increased with a peak response during 1-2 days after ulceration. Vascular content in the ulcerated mucosa as measured by carmine incorporation was decreased when the healing was impaired by indomethacin and L-NAME given for either the first or last 3 days as well as aminoguanidine given for the first 3 days. These results suggest that endogenous NO plays a role in healing of intestinal lesions, in addition to prostaglandins, yet the NOS isozyme mainly responsible for NO production differs depending on the stage of healing: iNOS in the early stage and cNOS in the late stage.     

MAPK信号途径在一氧化氮抑制大鼠心肌肥大中的作用

实验观察了一氧化氮（NO）前体L－精氨酸对肾性高血压大鼠心肌组织eNOS蛋白表达及亚硝酸盐／硝酸盐含量、MKP－1蛋白表达及MAPK活性的影响,以及与心肌肥厚的关系,采用两肾一夹Goldblatt肾性高血压模型,随机分为5组：L－精氨酸高、中、低剂量组,分别于术后第5周给予L－精氨酸50、150及450mg/kg;L－NAME组,腹腔注射L－NAME 10mg/kg,同时给予L－精氨酸150mg/kg;高血压对照组,正常饮水,以及另设的一假手术对照组。用药8周后,用插管法测量大鼠动脉血压、左心室重与体重比值,用胶内原位磷酸化法测MFAPK活性、免疫印迹法检测心肌组织eNOS及MKP－1蛋白表达、酶还原法测定心肌组织亚硝酸盐／硝酸盐－硝酸盐含量。结果表明：（1）L－精氨酸可明显抑制肾动脉狭窄术后的血压升高、左心室重与体重比增加,增加心肌组织eNOS、MKP-1蛋白表达及亚硝酸盐－硝酸盐含量,降低心肌组织MAPK活性,其中以150mg/kg组作用最为明显;（2）NOS抑制剂L－NAME可明显抑制－精氨酸的以上作用,肾性高血压大鼠心肌组织eNOS蛋白表达下降。NO生成减少及MKP－1蛋白表达下降以及MAPK活性增强可能与高血压及心肌厚形成有关,L－精氨酸通过促进心肌组织eNOS蛋白表达、增加NO产生和MKP－1表达、减弱MAPK活性而发挥抗高血压及心肌肥厚的作用。     

Ultrastructural localization of nitric oxide synthase and endothelin in coronary and pulmonary arteries of newborn rats

This is the first report on the ultrastructural distribution of nitric oxide synthase and endothelin immunoreactivities in the coronary and pulmonary arteries of newborn Wistar rats. The distribution of nitric oxide synthase and endothelin was investigated using pre-embedding peroxidase-antiperoxidase immunocytochemistry. In both arteries examined, positive labelling for nitric oxide synthase was localized both in the endothelium and smooth muscle, whereas positive labelling for endothelin was localized in the endothelium exclusively. In the coronary artery, approximately 80% and 55% of the endothelial cells examined were positive for nitric oxide synthase and endothelin, respectively, whereas in the pulmonary artery, 77% and 60% of the endothelial cells were positive for nitric oxide synthase and endothelin, respectively. These findings indicate that nitric oxide synthase and endothelin are colocalized in some of the endothelial cells of the newborn rat. In the endothelium, nitric oxide synthase and endothelin immunoreactivities were distributed throughout the cell cytoplasm and in association with the membranes of intracellular organelles. In smooth muscle, a relationship of nitric oxide synthase immunoreactivity to endoplasmic reticulum was observed in the pulmonary artery. In summary, in the newborn rat, endothelial cells of the coronary and pulmonary artery are rich in nitric oxide synthase (neuronal isoform) and endothelin, and it is suggested therefore that they may be substantially involved in vasomotor control of the cardiac and pulmonary circulation during early stages of postnatal development.     

HIF-1alpha-prolyl hydroxylase: molecular target of nitric oxide in the hypoxic signal transduction pathway

We have investigated inhibitory mechanisms of hypoxic activation of HIF-1alpha by nitric oxide (NO). Using a Hep3B cell-derived cell line, HRE7 cells, we found that the inhibition of HIF-1alpha activity by NO requires a substantial amount of oxygen, albeit at a lower level. We further investigated the effect of NO on the binding activity of the von Hippel-Lindau tumor suppressor protein (pVHL) to the N-terminal activation domain (NAD) overlapping the oxygen-dependent degradation domain (ODD) of HIF-1alpha, because this reaction involves prolyl hydroxylation in NAD that requires oxygen. Although we could not detect any binding activity when NAD was incubated with whole cell extracts from cells treated with CoCl(2) or desferrioxamine, the binding capacity was manifested when Hep3B cells were treated together with NO. This activation was also observed when whole cell extracts from CoCl(2)-treated cells were incubated with NO. The prolyl hydroxylase from Hep3B cells treated with CoCl(2) was partially purified about 80-fold, and several enzymatic properties were examined. The enzyme required ferrous ion and 2-oxoglutaric acid. Strong activation of the prolyl hydroxylase by NO was observed without further addition of ferrous ion.